These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 24562756)

  • 1. [Not Available].
    Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J
    Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 24562756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].
    Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J;
    Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 11963730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.
    Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J; ;
    Am Heart J; 2001 Feb; 141(2):200-5. PubMed ID: 11174332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
    Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR).
    Zahn R; Schiele R; Schneider S; Gitt AK; Wienbergen H; Seidl K; Bossaller C; Hauf GF; Gottwik M; Altmann E; Rosahl W; Senges J
    J Invasive Cardiol; 2001 May; 13(5):367-72. PubMed ID: 11385150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry.
    Zahn R; Schiele R; Schneider S; Dönges K; Senges J
    Z Kardiol; 2003 Oct; 92(10):847-51. PubMed ID: 14579049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.
    Zahn R; Schuster S; Schiele R; Seidl K; Voigtländer T; Meyer J; Hauptmann KE; Gottwik M; Berg G; Kunz T; Gieseler U; Jakob M; Senges J
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):127-33. PubMed ID: 10348528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry.
    Puymirat É; Aissaoui N; Silvain J; Bonello L; Cuisset T; Motreff P; Bataille V; Durand E; Cottin Y; Simon T; Danchin N;
    Arch Cardiovasc Dis; 2012; 105(6-7):347-54. PubMed ID: 22800719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial.
    Lavi S; Cantor WJ; Casanova A; Tan MK; Yan AT; Džavík V; Fitchett D; Cohen EA; Borgundvaag B; Heffernan M; Ducas J; Goodman SG
    Am Heart J; 2012 Feb; 163(2):176-81.e2. PubMed ID: 22305834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
    De Luca G; Marino P
    Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial.
    Cohen M; Gensini GF; Maritz F; Gurfinkel EP; Huber K; Timerman A; Krzeminska-Pakula M; Santopinto J; Hecquet C; Vittori L;
    Circulation; 2003 Oct; 108(16 Suppl 1):III14-21. PubMed ID: 14605015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Every NR; Parsons LS; Angeja B; Goldberg RJ; Gore JM; Chou TM;
    Am Heart J; 2001 Jun; 141(6):933-9. PubMed ID: 11376306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of direct coronary angioplasty in the course of acute myocardial infarction].
    Sheiban I; Tonni S; Trevi G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):129-42. PubMed ID: 8020010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of the acute myocardial infarction guidelines on in-hospital managements and outcome of the patients in China].
    Li J; Jin ZN; Chen YD; Lu SZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):649-55. PubMed ID: 21122198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR).
    Gottwik M; Zahn R; Schiele R; Schneider S; Gitt AK; Fraunberger L; Bossaller C; Glunz HG; Altmann E; Rosahl W; Senges J;
    Eur Heart J; 2001 Oct; 22(19):1794-801. PubMed ID: 11549301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.